Adaptive Biotechnologies (NASDAQ:ADPT) stock rises as Goldman Sachs upgrades to 'Buy,' citing an attractive end market. Read more here.

Researchers in Portugal have simulated 800 power purchase agreemeents across eight different contract type and have found ...

The award was presented at the national seminar on ‘Climate Resilient Agriculture in the Facet of Transition in Agriculture ...

Explore how adjuvant osimertinib aids in detecting molecular residual disease in resected EGFR-mutated NSCLC, offering ...